Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Cash & Equivalents (2016 - 2026)

Harrow has reported Cash & Equivalents over the past 15 years, most recently at $94.6 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 41.84% year-over-year to $94.6 million; the TTM value through Mar 2026 reached $94.6 million, up 41.84%, while the annual FY2025 figure was $72.9 million, 54.35% up from the prior year.
  • Cash & Equivalents for Q1 2026 was $94.6 million at Harrow, up from $72.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $96.3 million in Q4 2022 and troughed at $19.2 million in Q1 2023.
  • A 5-year average of $60.7 million and a median of $66.7 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 544.96% in 2022 and later crashed 54.11% in 2023.
  • Year by year, Cash & Equivalents stood at $96.3 million in 2022, then fell by 23.04% to $74.1 million in 2023, then tumbled by 36.23% to $47.2 million in 2024, then skyrocketed by 54.35% to $72.9 million in 2025, then rose by 29.78% to $94.6 million in 2026.
  • Business Quant data shows Cash & Equivalents for HROW at $94.6 million in Q1 2026, $72.9 million in Q4 2025, and $74.3 million in Q3 2025.